Are you aged 65 or older?
Take part in a study assessing an investigational study vaccine to prevent respiratory syncytial virus (RSV) disease. Older adults are at an increased risk of developing serious complications, including inflammation of the lungs or pneumonia, from respiratory syncytial virus, or RSV. Insurance is not needed to participate in this study.
- are 65 years of age or older
- are able to use smartphones, tablets, and/or computers
- Study-related medical care at no cost
- Compensation up to $500 for time and travel